C 
Cannabis Bioscience International Holdings CBIH · USD
Materials · US listing · 🇺🇸 United States
0.00
0.00%
Close of 6 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in USD, from our data supplier.
Revenue
$303,022
FY2018FY2025
Net income
−$548,820
FY2018FY2025
Free cash flow
−$329,631
FY2018FY2025
Shareholders' equity
−$1.2m
FY2018FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $303,022 | $248,841 | $316,825 | $214,980 | $761,737 | $580,220 | $97,856 | $39,500 |
| Gross profit | $262,916 | $203,242 | $223,375 | $168,217 | $758,092 | $580,220 | $97,856 | $39,500 |
| Operating income | −$421,365 | −$486,140 | −$983,370 | −$888,060 | −$114,960 | −$228,810 | −$2,710 | −$1.3m |
| Net income | −$548,820 | −$651,345 | −$1.0m | −$885,171 | −$159,308 | −$226,463 | −$2,706 | −$1.3m |
| Diluted earnings per share | -0.00 | -0.06 | -0.10 | -0.10 | -0.02 | -0.03 | -0.00 | -0.28 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | |
|---|---|---|---|---|---|---|---|---|
| Total assets | $31,880 | $57,162 | $43,382 | $109,894 | $148,789 | $127,654 | — | — |
| Cash and short-term investments | $12,952 | $755 | $8,913 | $31,981 | $41,322 | $127,654 | — | — |
| Total liabilities | $1.2m | $1.1m | $635,047 | $470,945 | $449,959 | $200,688 | — | — |
| Debt | $420,229 | $436,873 | $389,934 | $386,897 | $422,805 | $197,000 | — | — |
| Shareholders' equity | −$1.2m | −$1.1m | −$591,665 | −$361,051 | −$301,170 | −$73,033 | — | — |
| Shares outstanding | 11,627m | 10m | 10m | 9m | 8m | 9m | 6m | 5m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | −$329,627 | −$479,382 | −$913,160 | −$855,704 | −$507,705 | −$223,040 | — | −$6,836 |
| Capital spending | −$4 | — | — | — | — | — | — | — |
| Free cash flow | −$329,631 | −$479,382 | −$913,160 | −$855,704 | −$507,705 | −$223,040 | — | −$6,836 |
Latest quarters
By quarter end
| Feb 2026 | Nov 2025 | Aug 2025 | May 2025 | Feb 2025 | Nov 2024 | Aug 2024 | May 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $11,205 | $53,266 | $24,200 | $34,956 | $14,931 | $74,248 | $178,887 | $75,862 |
| Gross profit | −$40,794 | $42,766 | −$32,463 | $30,411 | −$4,465 | $66,445 | $170,525 | $65,984 |
| Operating income | −$93,259 | −$95,877 | −$74,784 | −$122,990 | −$109,041 | −$51,824 | −$97,604 | −$29,634 |
| Net income | −$103,933 | −$116,966 | −$82,645 | −$211,744 | −$181,243 | −$79,528 | −$76,305 | −$135,935 |
| Diluted earnings per share | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.01 | -0.01 | -0.01 |
| Total assets | $1,544 | $22,131 | $18,942 | $31,880 | $14,886 | $34,766 | $46,280 | $57,162 |
| Cash and short-term investments | $90 | $132 | $223 | — | $548 | $1,002 | $969 | $755 |
| Debt | $406,140 | $406,241 | $163,003 | $249,500 | $440,952 | $474,004 | $392,956 | $431,967 |
| Shareholders' equity | −$1.5m | −$1.4m | −$1.2m | −$1.2m | −$1.2m | −$1.2m | −$1.1m | −$1.1m |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 12.1% | -12.2% | -41.7% |
| Operating income | -22.0% | 13.0% | — |
| Net income | -14.7% | 19.4% | — |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 84.5% | 79.2% | 90.5% | 26.4% |
| Operating margin | -164.4% | -256.4% | -128.7% | 15.5% |
| Net margin | -217.5% | -287.7% | -144.4% | 1.2% |
Valuation history
At each fiscal year end
| FY2025 | FY2021 | |
|---|---|---|
| Price to earnings | -2.6 | -0.0 |
| Price to sales | 4.8 | — |
Share price return
Finished calendar years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Return | 60% | -40% | 254% | -62% | 250% | 38300% | 23% | 6707% | 615% | 289% |
Dividends and splits
Per share, in the currency the company pays
Paid for 0 years.
- 10-to-1 reverse split · 28 Sept 2009
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.